{
    "popularityCurve": {
        "data": [
            1,
            1,
            2,
            1,
            5,
            1,
            1,
            1,
            1,
            1,
            2,
            1,
            1,
            1,
            1,
            1,
            1,
            1,
            2,
            1,
            1,
            1,
            1
        ],
        "xLabels": [
            "00:00",
            "00:09",
            "00:51",
            "01:05",
            "01:19",
            "01:27",
            "01:33",
            "01:47",
            "02:14",
            "02:15",
            "02:25",
            "02:52",
            "03:11",
            "03:20",
            "03:24",
            "03:27",
            "03:29",
            "03:54",
            "04:13",
            "04:21",
            "04:33",
            "04:46",
            "04:51"
        ],
        "label": {
            "phrase": "the results of the present study show a marked increase in antiviral effect in patients when ribavirin is added to the combination of r1626 and peginterferon alfa-2a",
            "count": 2
        }
    },
    "clusterList": [
        {
            "phrase": "the results of the present study show a marked increase in antiviral effect in patients when ribavirin is added to the combination of r1626 and peginterferon alfa-2a",
            "count": 2
        },
        {
            "phrase": "this phase 2a study has demonstrated a potent reduction in hcv rna by r1626 and high viral responses with up to 74 percent rapid viral response after 4 weeks of treatment the strong antiviral effect between r1626 peginterferon alfa-2a and ribavirin suggests that the dose of one or both of these agents could be lowered to improve tolerability without significantly compromising efficacy",
            "count": 2
        },
        {
            "phrase": "we wanted to know whether a drug specific for ppar delta would have the same beneficial effects",
            "count": 2
        },
        {
            "phrase": "but now we are beginning to segregate out different therapeutic targets and develop drugs that have an impact on each target so in combination they may handle the disease better than any single approach",
            "count": 2
        },
        {
            "phrase": "we kept the patient comfortable with high doses of antibiotics and painkillers but medevac was the only option we had for definitive treatment",
            "count": 1
        },
        {
            "phrase": "our studies also have relevance to the formulation development of new medicines to make sure that patients get the right drug at the right amount at the right time",
            "count": 1
        },
        {
            "phrase": "people escape conventional medicine because they believe that these phony medicines have no side effects because the advertiser claims it is 100 per cent herbal",
            "count": 1
        },
        {
            "phrase": "fully informed patients and their physicians should have the choice to use this important medication which is the only therapeutic alternative to blood transfusions",
            "count": 1
        },
        {
            "phrase": "we've said all along and the fda has also stated and it's clearly outlined in our label that we expect to see additional cases of pml",
            "count": 1
        },
        {
            "phrase": "right now there are safety issues with ips cells including a risk of cancer we also don't know how to reintroduce cells into a sick adult in a way that will be beneficial all these hurdles need to be overcome first before we can think about using the cells to treat disease but we can start immediately to evaluate them as a tool for drug discovery",
            "count": 1
        },
        {
            "phrase": "the research we have published is an early but important step in unraveling the important pathways that will facilitate development of new treatments",
            "count": 1
        },
        {
            "phrase": "fda needs to assure us that there is quality control for generic medications sold in u s",
            "count": 1
        },
        {
            "phrase": "a new drug halts the devastating progress of alzheimer's disease say british scientists",
            "count": 1
        },
        {
            "phrase": "omjpi's proven capabilities in developing and marketing pain therapeutics make them an ideal partner to bring this potentially important molecule to patients who suffer chronic pain",
            "count": 1
        },
        {
            "phrase": "now it needs to be paired with clinical trials for new approaches for prevention",
            "count": 1
        },
        {
            "phrase": "it is the most potent concentration of health-promoting resveratrol best of all it is available today without a prescription",
            "count": 1
        },
        {
            "phrase": "in prospective placebo-controlled trials no adverse effects were observed to occur at a frequency of more than 5 and no difference in frequency was noted between the placebo and",
            "count": 1
        },
        {
            "phrase": "a drug used to treat fungus infections known allergy to this drug prohibits use side effects include blood clots blood defects kidney problems nausea and fever when used on the skin allergic reactions can occur",
            "count": 1
        },
        {
            "phrase": "evaluate strictly the therapeutic efficacy of ge-132",
            "count": 1
        },
        {
            "phrase": "widespread through big pharma",
            "count": 1
        },
        {
            "phrase": "we are pleased with the fda advisory committee's very positive recommendation for actemra which helps move this promising new therapy closer to becoming available for patients who suffer from the debilitating symptoms of ra based on the compelling data presented and this positive recommendation from the committee we remain hopeful that the fda will approve actemra for the treatment of ra and provide a new option to patients who are not achieving adequate symptom relief with current therapies",
            "count": 1
        },
        {
            "phrase": "valproate the active ingredient in stavzor is recommended by the american psychiatric association as a first-line therapy for patients living with bipolar disorder and experiencing manic episodes",
            "count": 1
        },
        {
            "phrase": "the approval of stavzor is an important development for patients who use valproate products and for our company",
            "count": 1
        },
        {
            "phrase": "small market drugs big price tags are drug companies exploiting people with rare diseases",
            "count": 1
        },
        {
            "phrase": "this will be an immense help as we try to uncover the mechanisms behind this disease and screen for drugs that can prolong life",
            "count": 1
        },
        {
            "phrase": "the high incidence of adverse effects associated with currently available medications has created great interest in the search for an effective and safe alternative treatment",
            "count": 1
        }
    ]
}